SCHEMBL5320574

SCHEMBL5320574

NC(CC1=CCc2ccccc21)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.50
ALPI P09923 1/20 0.50
PKM P14618 1/20 0.50
PTGS1 P23219 1/20 0.50
XIAP P98170 1/20 0.50
HTR6 P50406 1/20 0.45
SLC1A3 P43003 2/20 0.41
SLC1A2 P43004 2/20 0.41
SLC1A1 P43005 2/20 0.41
MAPK1 P28482 1/20 0.40
NOS3 P29474 2/20 0.40
NOS1 P29475 2/20 0.40
NOS2 P35228 2/20 0.40
HDAC8 Q9BY41 2/20 0.40
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
MPO P05164 1/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20362355 1.00 SLC7A5 (0.50) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL13607877 1.00 SLC7A5 (0.50) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL26552667 0.86 HTR6 (0.44) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL22927954 0.86 HTR6 (0.44) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL5329852 0.85 HTR6 (0.43) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL26552691 0.84 HTR6 (0.42) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL14189738 0.82 HTR6 (0.41) HTR6HDAC8KMT2AKIF11
SCHEMBL16884603 0.81 HTR6 (0.42) HTR6KDM4EMAPTKMT2A
SCHEMBL15030997 0.81 HTR6 (0.42) HTR6KDM4EMAPTKMT2A
SCHEMBL26008190 0.81 SLC7A5 (0.47) SLC7A5ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322859-A1 BICYCLIC PEPTIDYL INHIBITORS OHIO STATE INNOVATION FOUNDATION 2023-10-12 US disclosed
US-9867845-B2 Vectors for delivery of agents across biological membranes THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-01-16 US disclosed
US-20170267689-A1 STIMULI-SWITCHABLE MOIETIES, MONOMERS AND POLYMERS INCORPORATING STIMULI-SWITCHABLE MOIETIES, AND METHODS OF MAKING AND USING SAME THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2017-09-21 US disclosed
US-9630989-B2 Dipeptide analogs for treating conditions associated with amyloid fibril formation RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2017-04-25 US disclosed
US-20160030590-A1 VECTORS FOR DELIVERY OF AGENTS ACROSS BIOLOGICAL MEMBRANES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2016-02-04 US disclosed
US-20150322110-A1 DIPEPTIDE ANALOGS FOR TREATING CONDITIONS ASSOCIATED WITH AMYLOID FIBRIL FORMATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2015-11-12 US disclosed
US-9096645-B2 Dipeptide analogs for treating conditions associated with amyloid fibril formation RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2015-08-04 US disclosed
US-20130225512-A1 DIPEPTIDE ANALOGS FOR TREATING CONDITIONS ASSOCIATED WITH AMYLOID FIBRIL FORMATION MERZ PHARMA GMBH & CO. KGAA (DE) 2013-08-29 US disclosed
US-20120289571-A1 POLYMERIC CONJUGATES OF AROMATIC AMINE CONTAINING COMPOUNDS INCLUDING RELEASABLE UREA LINKER ENZON PHARMACEUTICALS, INC. (US) 2012-11-15 US disclosed
US-20080125452-A1 Indolopyridines,Benzofuranopyridines and Benzothienopyridines ALTANA PHARMA AG (DE) 2008-05-29 US disclosed
US-20080114017-A1 Novel Indolopyridines, Benzofuranopyridines and Benzothienopyridines 4SC AG (DE) 2008-05-15 US disclosed
US-20070258899-A1 Diagnostic and therapeutic agents KARYON-CTT LTD (FI) 2007-11-08 US disclosed
WO-2007113385-A1 DIAGNOSTIC AND THERAPEUTIC AGENTS KARYON-CTT LTD (FI) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114017-A1 Novel Indolopyridines, Benzofuranopyridines and Benzothienopyridines BAX, API5, AIFM1 SLC7A5 4164/4885ALPI 3874/4885PKM 2198/4885
US-20160030590-A1 VECTORS FOR DELIVERY OF AGENTS ACROSS BIOLOGICAL MEMBRANES BST2, CD2BP2, LNPEP SLC7A5 1313/4885ALPI 3975/4885PKM 4349/4885
US-20150322110-A1 DIPEPTIDE ANALOGS FOR TREATING CONDITIONS ASSOCIATED WITH AMYLOID FIBRIL FORMATION IAPP, APP, APBA1 SLC7A5 899/4885ALPI 1362/4885PKM 3573/4885
US-20170267689-A1 STIMULI-SWITCHABLE MOIETIES, MONOMERS AND POLYMERS INCORPORATING STIMULI-SWITCHABLE MOIETIES, AND METHODS OF MAKING AND USING SAME PASK, PAM, PTMS SLC7A5 3582/4885ALPI 4859/4885PKM 467/4885
US-20230322859-A1 BICYCLIC PEPTIDYL INHIBITORS NFKBIA, IKBKG, NFRKB SLC7A5 1683/4885ALPI 4802/4885PKM 1575/4885
US-20130225512-A1 DIPEPTIDE ANALOGS FOR TREATING CONDITIONS ASSOCIATED WITH AMYLOID FIBRIL FORMATION IAPP, APP, APBA1 SLC7A5 924/4885ALPI 1601/4885PKM 3261/4885
US-20120289571-A1 POLYMERIC CONJUGATES OF AROMATIC AMINE CONTAINING COMPOUNDS INCLUDING RELEASABLE UREA LINKER AURKA, DSTYK, TYR SLC7A5 244/4885ALPI 1925/4885PKM 959/4885
US-20080125452-A1 Indolopyridines,Benzofuranopyridines and Benzothienopyridines BAX, AIFM1, API5 SLC7A5 4214/4885ALPI 3577/4885PKM 2071/4885
US-20070258899-A1 Diagnostic and therapeutic agents YBX1, MLX, TPX2 SLC7A5 3712/4885ALPI 533/4885PKM 3848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.